[EN] COMPOUNDS AND COMPOUNDS FOR USE IN METHODS FOR TREATING DISEASES OR CONDITIONS MEDIATED BY PROTEIN DISULFIDE ISOMERASE [FR] COMPOSÉS ET COMPOSÉS DESTINÉS À ÊTRE UTILISÉS DANS DES MÉTHODES DE TRAITEMENT DE MALADIES OU D'ÉTATS MÉDIÉS PAR LA PROTÉINE DISULFIDE ISOMÉRASE
[EN] COMPOUNDS AND COMPOUNDS FOR USE IN METHODS FOR TREATING DISEASES OR CONDITIONS MEDIATED BY PROTEIN DISULFIDE ISOMERASE [FR] COMPOSÉS ET COMPOSÉS DESTINÉS À ÊTRE UTILISÉS DANS DES MÉTHODES DE TRAITEMENT DE MALADIES OU D'ÉTATS MÉDIÉS PAR LA PROTÉINE DISULFIDE ISOMÉRASE
An iodosylbenzene - iron tetraarylporphyrin catalyst system decarboxylated α-aryl carboxylic acids and α,α,α-trisubstituted aceticacids efficiently to give the corresponding alcohol and carbonyl derivatives.
Carboxamide derivatives as muscarinic receptor antagonists
申请人:Glossop Alan Paul
公开号:US20070105831A1
公开(公告)日:2007-05-10
The invention relates to compounds of formula
processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
本发明涉及具有下列公式的化合物、其制备方法和中间体,以及包含它们的抗胆碱能药物组合物。
Carboxamide Derivatives As Muscarinic Receptor Antagonists
申请人:Glossop Paul Alan
公开号:US20100029720A1
公开(公告)日:2010-02-04
The invention relates to compounds of formula
processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
COMPOUNDS AND COMPOUNDS FOR USE IN METHODS FOR TREATING DISEASES OR CONDITIONS MEDIATED BY PROTEIN DISULFIDE ISOMERASE
申请人:THE BROAD INSTITUTE, INC.
公开号:US20160145209A1
公开(公告)日:2016-05-26
The invention provides compounds of formula (I) that inhibit PDI, for use in methods to treat or prevent a disease or condition in a subject that would benefit by inhibition of PDI. Formula (I)
Micro-electro-flow catalyzed (μ-EFC) ultra-fast cross-electrophile coupling of activated C(sp<sup>3</sup>)–O bonds
作者:Sanjeev Kumar、Ajay K. Singh
DOI:10.1039/d3gc03239f
日期:——
cross-electrophile coupling of activated C(sp3)–O bonds with CO2 to generate aliphatic carboxylic acids via sequential reactions of sulfonium salts followed by replacement of CO2 with CS2, an aldehyde, a ketone, and electron-deficient olefins, to obtain the corresponding dithiol acid, deoxygenated Barbier-type product, and 1,4-addition product.